Concepedia

Rosalin Arends

RA

16

Publications

1.3K

Citations

14

H-Index

1994

Active since

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

University of Washington

Amgen (United States)

AstraZeneca (Poland)

Rosalin Arends is an author at Pfizer (United States) specializing in medicine, pharmacotherapy, and radiation oncology.

Top concepts

Publications per year

1994–2022

16

Publications

16

Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer

Eric K. Rowinsky, Garry Schwartz, Jared Gollob et al. · Journal of Clinical Oncology · 2004 · 323 citations · Full text

Comparative Spinal Distribution and Clearance Kinetics of Intrathecally Administered Morphine, Fentanyl, Alfentanil, and Sufentanil

W. Ummenhofer, Rosalin Arends, Danny D. Shen et al. · Anesthesiology · 2000 · 318 citations · Full text

Sequential Protein and Peptide Immunoaffinity Capture for Mass Spectrometry-Based Quantification of Total Human β-Nerve Growth Factor

Hendrik Neubert, David Muirhead, Musarat Kabir et al. · Analytical Chemistry · 2012 · 126 citations

Dose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid Malignancies

Louis M. Weiner, Arie S. Belldegrun, Jeffrey Crawford et al. · Clinical Cancer Research · 2008 · 124 citations

Assessment of the pharmacology and tolerability of PF‐04457845, an irreversible inhibitor of fatty acid amide hydrolase‐1, in healthy subjects

Gai Ling Li, Helen Winter, Rosalin Arends et al. · British Journal of Clinical Pharmacology · 2011 · 123 citations · Full text

Rows per page

1–5 of 16